Capillary electrophoresis provides rapid, accurate, and reliable analytical solutions for characterizing and evaluating biopharmaceutical products throughout the drug development process. At Avance Biosciences™, we offer cutting-edge CGMP and GLP-compliant services to assist your biopharmaceutical development. Our commitment to innovation extends to our analysis and separation platforms, including the SCIEX PA800 Plus capillary electrophoresis system.


  • High-Throughput Analysis: The SCIEX PA800 Plus enables rapid and high-throughput analysis of biomolecules, including proteins, peptides, and nucleic acids.

  • Precise Separation: With advanced capillary electrophoresis technology, it provides precise separation of complex mixtures, allowing for accurate characterization of biopharmaceutical samples.

  • Assay Development: Our platform facilitates assay development for various biopharmaceuticals, ensuring robust and reliable analytical methods for product characterization and quality control.

  • Assay Validation: We utilize the SCIEX PA800 Plus for assay validation, ensuring that our methods meet regulatory requirements and industry standards for biopharmaceutical development.

  • Sample Testing: From purity assessment to impurity profiling, our platform offers comprehensive sample testing services to support every stage of biopharmaceutical development.

How We Can Help:

  • Accelerated Development: By leveraging the automation capabilities of the SCIEX PA800 Plus, we expedite the development process, reducing time-to-market for biopharmaceutical products.

  • Enhanced Efficiency: Our automated workflows streamline processes, minimizing manual intervention and optimizing resource utilization, leading to cost savings for our clients.

  • Data Integrity: With automated data acquisition and analysis, we ensure the integrity and reliability of results, providing our clients with accurate and actionable insights.

  • Regulatory Compliance: Our services adhere to CGMP and GLP regulations, guaranteeing the quality, safety, and efficacy of biopharmaceutical products for regulatory submission and approval.

At Avance Biosciences™, we empower biopharmaceutical developers with state-of-the-art analysis and separation platforms like the SCIEX PA800 Plus, delivering unparalleled expertise and support for their drug development endeavors. Contact us today to learn more about how we can accelerate your biopharmaceutical development initiatives.

SCIEX PA800 Plus System


When you partner with Avance Biosciences™, you gain a CRO partner that is creative, collaborative and dedicated to sound science with a focus on the regulatory requirements our partners require. Contact our technical staff to discuss how we can support you in your project!


Dedication to Quality

Dedication To Quality

The Avance Biosciences™ team is committed to strict adherence to CGMP and GLP regulations enacted by the US, European, Japanese, and other international regulatory agencies.


Extensive Experience

Open Communication

Our team has extensive knowledge and experience working with scientists, QA/QC professionals, and project managers from over 100 pharmaceutical and biotechnology companies and organizations throughout the world.


Open Communication

Open Communication

Transparency and integrity are two of our core values. Our well-trained, friendly, and professional study directors and project managers strive to complete your projects on-time with open communication channels and to your specifications.


Cutting Edge Science

Open Communication

Avance Biosciences™’ CGMP/GLP compliant genomic and microbial assays make use of the advanced technologies including real-time PCR, ddPCR, Sanger sequencing, next-gen sequencing, Southern blot, and more.